BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 236 filers reported holding BEAM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,746,920 | -25.8% | 72,637 | -1.4% | 0.00% | 0.0% |
| Q2 2023 | $2,353,145 | +5.0% | 73,697 | +0.7% | 0.00% | 0.0% |
| Q1 2023 | $2,240,527 | -22.9% | 73,172 | -1.6% | 0.00% | -40.0% |
| Q4 2022 | $2,907,789 | -16.9% | 74,349 | +1.2% | 0.01% | -16.7% |
| Q3 2022 | $3,500,000 | +22.8% | 73,468 | -0.2% | 0.01% | +20.0% |
| Q2 2022 | $2,850,000 | -2.6% | 73,633 | +44.2% | 0.01% | +25.0% |
| Q1 2022 | $2,926,000 | -34.4% | 51,068 | -8.7% | 0.00% | -20.0% |
| Q4 2021 | $4,459,000 | -2.5% | 55,949 | +6.5% | 0.01% | -16.7% |
| Q3 2021 | $4,572,000 | -45.1% | 52,546 | -18.8% | 0.01% | -40.0% |
| Q2 2021 | $8,334,000 | +73.0% | 64,751 | +7.6% | 0.01% | +66.7% |
| Q1 2021 | $4,816,000 | -2.3% | 60,165 | -0.3% | 0.01% | -14.3% |
| Q4 2020 | $4,927,000 | +274.1% | 60,347 | +12.8% | 0.01% | +250.0% |
| Q3 2020 | $1,317,000 | +151.8% | 53,480 | +186.5% | 0.00% | +100.0% |
| Q2 2020 | $523,000 | +55.7% | 18,669 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $336,000 | – | 18,669 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HSG Holding Ltd | 1,127,934 | $31,582,000 | 5.60% |
| Omega Fund Management, LLC | 302,821 | $8,479,000 | 2.32% |
| Redmile Group, LLC | 3,356,958 | $93,995,000 | 1.74% |
| BRANDYWINE MANAGERS, LLC | 10,875 | $305,000 | 1.25% |
| DC Investments Management, LLC | 88,100 | $2,467,000 | 0.91% |
| Alphabet Inc. | 663,691 | $18,583,000 | 0.86% |
| Cormorant Asset Management, LP | 796,429 | $22,036,000 | 0.84% |
| HHLR ADVISORS, LTD. | 2,966,403 | $83,059,000 | 0.76% |
| Temasek Holdings (Private) Ltd | 3,354,641 | $93,930,000 | 0.56% |
| Granahan Investment Management | 96,598 | $2,705,000 | 0.10% |